Literature DB >> 10525313

Dermal fibroblasts represent a potent major source of human eotaxin: In vitro production and cytokine-mediated regulation.

M Miyamasu1, T Nakajima, Y Misaki, S Izumi, N Tsuno, T Kasahara, K Yamamoto, Y Morita, K Hirai.   

Abstract

Accumulating evidence indicates that eotaxin plays an integral role in tissue recruitment of eosinophils in humans as well as in animals. To clarify which types of cells are actually important as sources of human eotaxin, we used a specific enzyme-linked immunosorbent assay (ELISA) to compare various types of hemopoietic and nonhemopoietic cells for the ability to produce eotaxin protein. Regardless of various conditioning, we failed to determine any significant eotaxin generation by peripheral leukocytes and vein endothelial cells (less than 20 pg/ml). A small amount of immunoreactive eotaxin was detected in cultures of A549 bronchial epithelial cell line cells. In contrast, dermal fibroblasts were capable of generating extremely high, and potentially biologically relevant, amounts of eotaxin protein (on the order of ng/ml). The eotaxin generation was induced by tumour necrosis factor alpha (TNF-alpha) or IL-4, and the production was drastically increased by combined use of these cytokines. Because fibroblasts are ideally situated within the interstium at the sites of allergic responses, our finding that these cells represent an important cellular source of eotaxin suggests that fibroblast-derived eotaxin may act to regulate eosinophil recruitment in a paracrine fashion. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10525313     DOI: 10.1006/cyto.1999.0487

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  7 in total

1.  Mycobacterium bovis bacillus Calmette-Guérin (BCG) induces human CC- and CXC-chemokines in vitro and in vivo.

Authors:  Y Luo; X Chen; M A O'Donnell
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

Review 2.  Exploring the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Glycyrrhizic and Glycyrrhetinic Acids.

Authors:  Seidu A Richard
Journal:  Mediators Inflamm       Date:  2021-01-07       Impact factor: 4.711

3.  Eotaxin-1/CCL11 is involved in cell migration in rheumatoid arthritis.

Authors:  Kuninobu Wakabayashi; Takeo Isozaki; Yumi Tsubokura; Sayaka Fukuse; Tsuyoshi Kasama
Journal:  Sci Rep       Date:  2021-04-12       Impact factor: 4.379

4.  Cytokines and chemokines multiplex analysis in patients with low disease activity rheumatoid arthritis.

Authors:  Maria Skrzypkowska; Mariusz Stasiak; Justyna Sakowska; Joanna Chmiel; Agata Maciejewska; Adam Buciński; Bartosz Słomiński; Piotr Trzonkowski; Piotr Łuczkiewicz
Journal:  Rheumatol Int       Date:  2022-02-18       Impact factor: 2.631

5.  5-lipoxygenase-dependent recruitment of neutrophils and macrophages by eotaxin-stimulated murine eosinophils.

Authors:  Ricardo Alves Luz; Pedro Xavier-Elsas; Bianca de Luca; Daniela Masid-de-Brito; Priscila Soares Cauduro; Luiz Carlos Gondar Arcanjo; Ana Carolina Cordeiro Faria dos Santos; Ivi Cristina Maria de Oliveira; Maria Ignez Capella Gaspar-Elsas
Journal:  Mediators Inflamm       Date:  2014-02-25       Impact factor: 4.711

6.  Betel chewing and arecoline affects eotaxin-1, asthma and lung function.

Authors:  Tsu-Nai Wang; Ming-Shyan Huang; Meng-Chih Lin; Tsai-Hui Duh; Chih-Hung Lee; Chin-Chou Wang; Ping-Ho Chen; Shang-Lun Chiang; Chau-Chyun Sheu; Vincent Chin-Hung Chen; Chao-Chien Wu; Cleusa P Ferri; Robert Stewart; Ying-Chin Ko
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

7.  Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line.

Authors:  Sachiko Matsui; Hiroatsu Matsumoto; Yoshiko Sonoda; Kumi Ando; Eriko Aizu-Yokota; Toshitsugu Sato; Tadashi Kasahara
Journal:  Int Immunopharmacol       Date:  2004-12-15       Impact factor: 4.932

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.